Medtronic MiniMed
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medtronic MiniMed sits in the top decile of US sponsors by registered trial count (#553 of 15,751 sponsors by registered trial count).
Medtronic MiniMed: 29 sponsored US clinical trials, 1 recruiting.
Medtronic MiniMed sponsors 29 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 28 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
Medtronic MiniMed ranks in the top decile of sponsors by registered trial count (#553 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
29 total, page 1 of 1
MiniMed Fit Payload Wear Pediatric Study
NCT07675161
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
NCT06604871
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®
NCT05325294
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
NCT05224258
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
NCT05238142
Use of the Guardian™ Connect System With Smart Connected Devices
NCT04809285
Feasibility Studies of Personalized Closed Loop
NCT04203823
Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
NCT04378114
Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices
NCT04020822
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
NCT03959423
Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics
NCT03966911
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home
NCT02748018
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes
NCT02660827
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
NCT02463097
CEP249 Pediatric Accuracy Study
NCT01991470
Adult Accuracy Study of the Enlite 3 Glucose Sensor
NCT02246582
Threshold Suspend in Pediatrics at Home
NCT02120794
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
NCT02003898
Overnight Closed Loop Study in U.S.
NCT01857973
Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)
NCT01763567
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
NCT01497938
A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use
NCT01464346
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
NCT01112696
An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance
NCT00865345
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
NCT00831389
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
NCT00530023
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes
NCT00211510
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
NCT00211536
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 1 |
Where Medtronic MiniMed enrollment is open (later-stage tilt)
1 recruiting of 29 indexed (3% open); 28 completed (97%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.